• ¿Documento equivocado? Cámbialo gratis
  • Escrito por estudiantes que aprobaron
  • Inmediatamente disponible después del pago
  • Leer en línea o como PDF
Vender
¿Dónde estudias?
Tu idioma
Document preview thumbnail
Vista previa 4 fuera de 113 páginas
Examen

NAMS Menopause Exam Q-Bank | Practice Questions & Answers | Study Guide | Latest Update

Document preview thumbnail
Vista previa 4 fuera de 113 páginas

NAMS Menopause Exam Q-Bank | Practice Questions & Answers | Study Guide | Latest Update The NAMS Menopause Exam Q-Bank covers key concepts related to menopause care, including menopausal transition, reproductive aging, common symptoms, hormonal changes, vasomotor symptoms, genitourinary health, bone health, cardiovascular considerations, and overall midlife health. It also reviews assessment approaches, clinical considerations, patient-centered care, and evidence-based management principles relevant to menopause practice. The question bank includes practice questions and answers designed to reinforce knowledge and support exam preparation. Major areas include hormone therapy principles, nonhormonal management options, symptom evaluation, risk–benefit considerations, contraindications and precautions, sexual health, osteoporosis prevention, lifestyle considerations, and individualized treatment planning. It can be used for structured review, self-assessment, and identifying areas that require additional study before the NAMS menopause examination.

Vista previa del contenido

1|Page



NAMS Menopause Exam Q-Bank | Practice

Questions & Answers | Study Guide | Latest

Update

EXAM COVERAGE SUMMARY

This 250-question Q-Bank covers the complete NAMS menopause medicine

curriculum including:

Menopause Staging & Transition — STRAW+10 criteria, early/late transition,

FMP definitions, POI diagnosis, surgical menopause, ethnic variations

Hormonal Physiology — HPO axis, FSH/LH patterns, AMH, inhibin B, AFC, LOOP

events, adrenal androgens, SHBG, free androgen index

Vasomotor Symptoms — Etiology theories, duration, ethnic differences, non-

hormonal and hormonal management

Genitourinary Syndrome — Vaginal atrophy, estrogen receptors, VIN, Paget's

disease, vulvar cancer, urinary incontinence

Osteoporosis — T/Z-score interpretation, fracture risk, bisphosphonates,

raloxifene, teriparatide, denosumab, atypical fractures

Hormone Therapy — Indications, risks/benefits, WHI/WHIMS studies, routes,

dementia risk, gallbladder disease, breast cancer considerations

,2|Page


Medical Comorbidities — Thyroid disorders, migraines, hepatitis C screening,

HPV, cardiovascular risk

Special Populations — POI, breast cancer survivors, endometriosis, fibroids,

ethnic differences, obesity



NAMS Menopause Exam Q-Bank




Question 1

A 52-year-old woman presents with complaints of hot flashes occurring 8-10 times daily. She is 3 years
past her final menstrual period. Her BMI is 31 kg/m². Which hormonal finding is most likely elevated in
this patient compared to a normal-weight woman at the same menopausal stage?

A. Estradiol
B. Progesterone
C. Estrone
D. Testosterone

Correct Answer: C

RATIONALE: Obese women have higher estrone levels due to peripheral aromatization of androgens in
adipose tissue. This explains their increased risk of endometrial cancer and why they often have higher
postmenopausal estradiol levels compared to normal-weight women.




Question 2

A 48-year-old woman reports irregular menstrual cycles with persistent differences of 8 days in cycle
length over the past 6 months. She has no other symptoms. According to the STRAW+10 staging system,
which stage best describes her current menopausal transition?

,3|Page


A. Stage -1
B. Stage -2
C. Stage -3a
D. Stage +1a

Correct Answer: B

RATIONALE: Early menopause transition (stage -2) is defined by a persistent difference of 7 days or more
in the length of consecutive cycles. This represents the onset of menstrual irregularity in the menopausal
transition.




Question 3

A 41-year-old woman has missed 4 consecutive menstrual periods. Laboratory testing reveals FSH of 32
mIU/mL on two occasions 5 weeks apart. What is the most appropriate diagnosis?

A. Premature ovarian failure
B. Primary ovarian insufficiency
C. Early menopause
D. Late menopause transition

Correct Answer: B

RATIONALE: Primary ovarian insufficiency is diagnosed in women under age 40 with menstrual
disturbance (oligomenorrhea or amenorrhea for at least 4 months) AND elevated FSH over 25 mIU/mL on
two occasions at least 4 weeks apart.




Question 4

A 55-year-old woman with a history of hypertension is considering hormone therapy for bothersome
vasomotor symptoms. She is 6 years postmenopausal. Which stage of menopause best describes her
current status?

A. Stage +1a
B. Stage +1b

, 4|Page


C. Stage +1c
D. Stage +2

Correct Answer: D

RATIONALE: Stage +2 represents late menopause, occurring 5-8 years after the final menstrual period.
During this stage, somatic aging predominates and genitourinary symptoms become more prominent.




Question 5

A 53-year-old woman reports severe hot flashes that are affecting her quality of life. She is 1 year past
her final menstrual period. Laboratory evaluation reveals elevated FSH and LH levels. Which statement
best explains the etiology of her hot flashes?

A. Elevated estrogen levels widen the thermoregulatory zone
B. Lower ovarian estradiol narrows the thermoregulatory zone
C. Increased progesterone causes hypothalamic dysfunction
D. Elevated LH directly triggers vasomotor instability

Correct Answer: B

RATIONALE: Hot flashes are thought to result from a narrowed thermoregulatory zone caused by lower
ovarian estradiol levels. Additional theories involve neurokinins regulating GnRH secretion, serotonin,
cortisol/HPI axis dysregulation, and endothelial dysfunction.




Question 6

A 58-year-old woman presents with vulvar itching and burning that has not improved with topical steroid
treatment. On examination, there is an erythematous, well-demarcated lesion on the labia majora. What
is the most likely diagnosis?

A. Lichen sclerosus
B. Vulvar Paget's disease
C. Squamous cell carcinoma
D. Contact dermatitis

Información del documento

Subido en
24 de agosto de 2026
Número de páginas
113
Escrito en
2026/2027
Tipo
Examen
Contiene
Preguntas y respuestas
$21.49

¿Documento equivocado? Cámbialo gratis Dentro de los 14 días posteriores a la compra y antes de descargarlo, puedes elegir otro documento. Puedes gastar el importe de nuevo.
Escrito por estudiantes que aprobaron
Inmediatamente disponible después del pago
Leer en línea o como PDF

Seller avatar
Los indicadores de reputación están sujetos a la cantidad de artículos vendidos por una tarifa y las reseñas que ha recibido por esos documentos. Hay tres niveles: Bronce, Plata y Oro. Cuanto mayor reputación, más podrás confiar en la calidad del trabajo del vendedor.
Vendido
9
Seguidores
0
Artículos
391
Última venta
3 semanas hace



Por qué los estudiantes eligen Stuvia

Creado por compañeros estudiantes, verificado por reseñas

Calidad en la que puedes confiar: escrito por estudiantes que aprobaron y evaluado por otros que han usado estos resúmenes.

¿No estás satisfecho? Elige otro documento

¡No te preocupes! Puedes elegir directamente otro documento que se ajuste mejor a lo que buscas.

Paga como quieras, empieza a estudiar al instante

Sin suscripción, sin compromisos. Paga como estés acostumbrado con tarjeta de crédito y descarga tu documento PDF inmediatamente.

Student with book image

“Comprado, descargado y aprobado. Así de fácil puede ser.”

Alisha Student

Preguntas frecuentes